Ajai R. Singh

Some Issues in Women’s Studies, and other Essays This theme monograph is called Some Issues in Women’s Studies, and other Essays. It has notable contributions on numerous issues in women’s studies along with some other write-ups. Robert M. Kaplan, Editor-in-Chief, Health Psychology; Fred W. and Pamela K. Wasserman Professor; Chair, Department of Health Services, University of California, Los Angeles, […]

Abstract Covert treatment raises a number of ethical and practical issues in psychiatry. Viewpoints differ from the standpoint of psychiatrists, caregivers, ethicists, lawyers, neighbours, human rights activists and patients. There is little systematic research data on its use but it is quite certain that there is relatively widespread use. The veil of secrecy around the

Psychiatrist, Teacher, Mentor,… Quietly Effulgent I have to record with deep sorrow and grief the demise in June 2007 of one of the doyens of clinical psychiatry in India, Prof. N.S. Vahia. Sharply arched eyebrows, deep-set eyes, soft spoken and gentle demeanour, excellent clinical skills, abiding interest in all branches of psychiatry, and a keen

The Jan-Dec 2008 issue of MSM is a theme issue on Medicine, Mental Health, Science, Religion and Well-being. Go to: Editorials C. Robert Cloninger, M.D. Wallace Renard Professor of Psychiatry, Genetics, and Psychology; Director, Sansone Center for Well-Being, writes an editorial, ‘On Well-Being: Current Research Trends and Future Directions’ [p3–9]. K.W.M. Fulford, DPhil, FRCP, FRCPsych. Professor of Philosophy and

Everyone has gone homebut you and the janitor. The nurseshave driven away, fluttering across the parking lotlike white confetti. Sparrows sing themselves to sleep and even the hospitallongs to dream. You read X-raysin the view box glow, your patients′ namesmarked in black, their lungssurprised in full inhale, hearts stoppedmid-pump, strangerswho keep you company as you

Ever since David Healy first announced in 1991 that SSRIs (selective serotonin reuptake inhibitors) have a causal role in some suicide cases, he has had to face ostracism from corporate psychiatry, has had a job offer from the University of Toronto withdrawn, been accused of practicing ‘junk science’ by the pharmaceutical industry and of covertly

http://groups.yahoo.com/group/mensanamonographs/ (The mensanamonographs e-group discusses a number of issues related to medicine, mental health, science, religion, philosophy, man and society. One such it discussed recently was the editorial, ‘To cure sometimes, to comfort always, to hurt the least, to harm never’, by Singh A. R., Singh S. A. (2006), in What Medicine Means To Me,

What is the ideal combination of increased investment in biomedical research by sponsors with least conflict of interest in researchers? What should interested parties do to refurbish pharma’s image? Is a voluntary moratorium on pharma spending practically possible? How to resolve the basic schism between profit driven industry and welfare driven profession of medicine? How

Private investment in biomedical research has increased over the last few decades. At most places it has been welcomed as the next best thing to technology itself. There are significant costs involved too. Major areas of conflict of interest especially applicable to biomedical research have arisen, as academia interacts with industry. Pharma image stinks because